Ani Pharmaceuticals (ANIP) Treasury Shares (2012 - 2026)

Ani Pharmaceuticals has disclosed Treasury Shares across 13 years of filings, most recently posting $53.8 million for Q2 2026.

• In Q2 2026, Treasury Shares rose 70.34% year-over-year to $53.8 million; the TTM figure through Jun 2026 stood at $53.8 million (up 70.34% YoY), while the FY2025 annual figure was $33.2 million, up 58.03% from the prior year.
• Treasury Shares came in at $53.8 million for Q2 2026 at Ani Pharmaceuticals, up from $53.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $891915.0 in Q2 2026 to a low of $123000.0 in Q1 2022.
• Average Treasury Shares over 5 years is $412501.4, with a median of $402773.0 recorded in 2024.
• Year-over-year, Treasury Shares soared 54.67% in 2022 and surged 118.32% in 2024.
• Over 5 years, Treasury Shares stood at $5.1 million in 2022, then surged by 97.9% to $10.1 million in 2023, then soared by 108.71% to $21.0 million in 2024, then jumped by 58.03% to $33.2 million in 2025, then jumped by 61.86% to $53.8 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $53.8 million in Q2 2026, $53.0 million in Q1 2026, and $33.2 million in Q4 2025.